arXiv Science⌕ Search

arXiv subjects

Melih Agraz

Publications and source records attributed to Melih Agraz.

3 recordsLinked to original sources

Synaptic Dendritic Neuron Model (scDNM) for Cell Type Classification in Single-Cell RNA Sequencing Data

Cell type classification in single-cell RNA sequencing (scRNA-seq) data is challenging because of high dimensionality, sparsity, and transcriptionally similar cell types. We developed scDNM, an adaptation of the dendritic neuron model incorporating learnable synaptic thresholds, a supervised gene pool, staged training, and ensemble prediction. Six binary classification tasks were constructed from the Paul15, PBMC3k, and Nestorowa datasets. All models were evaluated using leakage-free nested cross-validation, with feature selection, scaling, and hyperparameter tuning performed independently of the outer test folds. scDNM ranked first in three of six tasks (including one tie) and achieved the best mean accuracy rank (2.00), followed by XGBoost (2.75), Random Forest (3.33), logistic regression (3.33), and SVM (3.58). In a six-class PBMC3k experiment, scDNM achieved 95.997% accuracy and 0.944 macro-F1, compared with 94.243% and 0.914 for SingleR. Garnett returned only Unknown labels and was treated as a zero-coverage technical outcome. Ablation analysis supported the contributions of dendrites and synaptic thresholds. However, XGBoost achieved higher mean binary-task accuracy (96.20% versus 95.32% for scDNM), and across-task rank differences were not statistically significant. These findings demonstrate that scDNM is competitive for scRNA-seq cell type classification, although broader independent validation is required.

q-bio.GN↗

scDNM-VAE enables directly inspectable deep clustering of single-cell RNA-seq data through signed dendritic gating

Deep clustering models for single-cell RNA sequencing often assign cells through latent or centroid-based mechanisms that are difficult to inspect. We introduce scDNM-VAE (single-cell Dendritic Neuron Model Variational Autoencoder), a deep clustering framework that combines a variational autoencoder with a dendritic neuron-inspired head. Cluster assignments are governed by learnable signed synaptic weights and thresholds: the weight sign determines the direction of a gate's response to a latent coordinate, its magnitude controls steepness, and the weight-threshold pair determines the transition location. The trained clustering function can therefore be inspected directly without fitting a post-hoc explanation model. We benchmark scDNM-VAE on four datasets spanning immune, cortical, cardiac, and hematopoietic cells against scVI followed by KMeans and an MLP-DEC ablation. scDNM-VAE performs better than scVI on PBMC3k, comparably on the Human Heart Cell Atlas and Paul15, and worse on Zeisel, while producing biologically coherent marker-gene signatures. Ablating each cluster's three highest-magnitude synaptic dimensions causes numerically greater reassignment than random-dimension ablation across all datasets, but the margins are modest and negligible on Zeisel. These results show that signed dendritic gating supports competitive clustering with a parameter-inspectable decision function, while indicating that decision-relevant information is distributed across the latent space.

q-bio.QM↗

RGE-GCN: Recursive Gene Elimination with Graph Convolutional Networks for RNA-seq based Early Cancer Detection

Early detection of cancer plays a key role in improving survival rates, but identifying reliable biomarkers from RNA-seq data is still a major challenge. The data are high-dimensional, and conventional statistical methods often fail to capture the complex relationships between genes. In this study, we introduce RGE-GCN (Recursive Gene Elimination with Graph Convolutional Networks), a framework that combines feature selection and classification in a single pipeline. Our approach builds a graph from gene expression profiles, uses a Graph Convolutional Network to classify cancer versus normal samples, and applies Integrated Gradients to highlight the most informative genes. By recursively removing less relevant genes, the model converges to a compact set of biomarkers that are both interpretable and predictive. We evaluated RGE-GCN on synthetic data as well as real-world RNA-seq cohorts of lung, kidney, and cervical cancers. Across all datasets, the method consistently achieved higher accuracy and F1-scores than standard tools such as DESeq2, edgeR, and limma-voom. Importantly, the selected genes aligned with well-known cancer pathways including PI3K-AKT, MAPK, SUMOylation, and immune regulation. These results suggest that RGE-GCN shows promise as a generalizable approach for RNA-seq based early cancer detection and biomarker discovery (https://rce-gcn.streamlit.app/ ).

cs.LG↗